Related Experiment Videos
Management of endocrine orbitopathy
1Department of Otorhinolaryngology and Human Communication, University of Pennsylvania School of Medicine, Philadelphia.
Otolaryngologic Clinics of North America
|February 1, 1988
Summary
Endocrine ophthalmopathy, a common cause of proptosis, may threaten vision. Surgical decompression and radiation therapy are options for patients unresponsive to steroids, requiring multidisciplinary care.
Area of Science:
- Ophthalmology
- Endocrinology
- Otolaryngology
Background:
- Endocrine ophthalmopathy is the leading cause of proptosis in adults.
- A subset of patients experience vision-threatening complications.
- Prompt intervention is crucial for preserving sight.
Purpose of the Study:
- To outline current management strategies for endocrine ophthalmopathy.
- To discuss therapeutic options for vision-threatening cases.
- To emphasize the importance of a multidisciplinary approach.
Main Methods:
- Review of medical literature on endocrine ophthalmopathy management.
- Discussion of treatment modalities including steroids, surgery, and radiation.
- Highlighting the role of a collaborative team approach.
Main Results:
- High-dose steroids are the first-line medical management.
- Surgical decompression, particularly the Walsh-Ogura technique, is indicated for steroid-resistant cases.
- Radiation therapy serves as an alternative for refractory or unsuitable patients.
Conclusions:
- Management focuses on symptom relief and vision preservation.
- Surgical decompression is a key intervention for severe disease.
- A multidisciplinary team is essential for optimal patient outcomes.